Foreign
By Kennedy Nnamani
CORINE Karema has been appointed the interim Chief Executive Officer, CEO, of the Roll Back Malaria, RBM, Partnership to end malaria, following the departure of Abdourahmane Diallo, who was appointed in March 2019.
Before this appointment, Karema has been in the leadership team of this body after she had served as special advisor to the Board Chair of The Global Fund; a partnership designed to accelerate the end of AIDS, tuberculosis, and malaria as epidemics, following her role as Malaria Senior Programme Officer at the African Leaders Malaria Alliance, ALMA, and team leader of the malaria experts’ group of the Global Fund technical Panel review.
The Rwandan doctor has also spent over a decade leading the malaria control efforts in her country as director of the National Malaria Control Programme, NMCP, and she was the head of the Rwandan division of the Malaria & Other Parasitic Diseases (Neglected tropical diseases) Division.
While commenting and congratulating the new appointee, Professor Maha Barakat, Board Chair of the RBM Partnership to End Malaria, expressed her confidence that Karema will efficiently pilot the affairs of the Board
“Having held leadership and management roles within the malaria community at the national, regional, and global levels, we are confident that her extensive experience and technical expertise will prove invaluable,” she said.
“With experience leading Rwanda’s National Malaria Control Programme and working within The Global Fund, she is perfectly placed to lead the global community in advocating for political commitment to end malaria at the Commonwealth Heads of Government Meeting in Kigali later this year and again in the lead up to The Global Fund’s Seventh Replenishment conference,” she added.
While accepting this position, Karema noted that she has experienced first-hand the impact of this deadly, but preventive disease. She therefore promised to move the Board forward to achieve the objective of the RBM Partnership.
“In this role, I am dedicated to working with partners to continue the incredible work already in motion, deliver the RMB Partnership’s 2021-2025 strategic plans, and ultimately achieve our goal of ending malaria as an example epidemic by 2030.
“I look forward to collaborating with many more partners and an ever more diverse set of stakeholders worldwide over the coming months, starting with World Malaria Day on Monday, May 25,” she said.
The RBM Partnership to End Malaria is the largest global platform to coordinate action against malaria, mobilize action and resources and forge consensus among partners. The Partnership comprises more than 500 partners, including malaria-endemic countries, their bilateral and multilateral development partners, the private sector, non-governmental and community-based organizations, foundations, and research and academic institutions.
KN
Tags: Abdourahmane Diallo Dr. Corine Karema Professor Maha Barakat
